Integrating Herbal Medicine with Transdermal Drug Delivery: A Novel Approach to Vitiligo Management
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The treatment of vitiligo, a long-term depigmenting skin condition, is still quite difficult. Particularly with traditional oral or topical regimens, current treatments frequently encounter challenges such low Patient adherence, unfavourable side effects, and limited efficacy. This abstract investigates a new method of treating vitiligo by combining herbal remedies with transdermal drug delivery devices (tdds). Herbal compounds are attractive possibilities for vitiligo treatment because they provide a wealth of Naturally occurring bioactive chemicals with proven melanogenic, immunomodulatory, and antioxidant Qualities. However, poor skin penetration, degradation, and uneven bioavailability are common problems with topical administration. Patches, gels, microneedles, and nanoparticles are examples of transdermal. Drug delivery systems that offer a non-invasive, regulated, and targeted delivery platform that can get Over these restrictions. Herbal extracts can be formulated or encapsulated within tdds to improve Patient compliance, prolong therapeutic effects, decrease systemic toxicity, and increase percutaneous absorption. This synergistic approach has the potential to greatly increase the therapeutic efficacy of herbal remedies for vitiligo, providing a more secure, efficient, and patient-friendly therapy option. To thoroughly assess the pharmacokinetics, pharmacodynamics, safety, and clinical results of such integrated systems, more investigation is necessary.
Fields of Study & Subjects
Advancements in Transdermal Drug Delivery
melanin and skin pigmentation
Dermatologic Treatments and Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 30 March 2026
- Language
- EN